Marcos García Fuentes is a Professor at the Department of Pharmacology, Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela (USC), Spain. He leads the NANOBIOFAR research group focused on nanotechnologies for drug delivery systems and is affiliated with the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS). His expertise includes pharmaceutical biomaterials, cancer therapy, and gene delivery. He earned his PhD in 2004 from USC with a thesis on lipid nanoparticles for peptide transport, supervised by Dr. María José Alonso Fernández and Dr. Dolores Torres López. His research interests revolve around nanomedicine, particularly in designing drug delivery systems using polyphosphazenes, viral protein nanoparticles, and mRNA-activated matrices. He explores applications in glioblastoma treatment, cancer immunotherapy, and regenerative medicine. His work bridges biomaterials science with pharmaceutical innovation, addressing challenges in targeted drug delivery and controlled release systems. Recent publications highlight advancements in gene therapy via polyphosphazene derivatives, protamine-based nanotherapeutics, and self-assembled peptide-polymer hybrids. His contributions span oncology, immunology, and tissue engineering, with a focus on translating nanotechnologies into clinical applications. No scientific awards are explicitly mentioned, but his prolific publication record underscores his impact in the field. He advises research in biomaterials and drug delivery systems through CIMUS and the NANOBIOFAR group. His lab develops platforms for cancer treatment, stem cell differentiation, and chronic disease management. Collaborations include multidisciplinary projects in biomaterial design, pharmaceutical formulation, and nanomedicine.








